跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
TGA
/
ATOVACUE atovaquone 750 mg/5 mL oral liquid suspension bottle
Approved
STANDARD
ATOVACUE atovaquone 750 mg/5 mL oral liquid suspension bottle
Glenmark Pharmaceuticals Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
e884f594dcff6b89
Company
Glenmark Pharmaceuticals Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
e884f594dcff6b89
Product Name
ATOVACUE atovaquone 750 mg/5 mL oral liquid suspension bottle
Artg Id
407150
Artg Name
ATOVACUE atovaquone 750 mg/5 mL oral liquid suspension bottle
Sponsor
Glenmark Pharmaceuticals Australia Pty Ltd
Company Detail Path
/organization/glenmark-pharmaceuticals-australia-pty-limited
Artg Date
2024-04-09
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/0a8c94fd771d2fe2ceb8750cd2c1b5d5.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/2da1cd2e7a53e94925b392a2d432b955.pdf
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
e884f594dcff6b89
Type
Standard
Back to TGA Approvals
ATOVACUE atovaquone 750 mg/5 mL oral liquid suspension bottle - TGA Drug Approval Details
